Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Jan 11, 2024 6:12pm
119 Views
Post# 35822589

RE:RE:RE:FDA Approval…

RE:RE:RE:FDA Approval…Forshure, "quantum shift" is well in motion..beginning many years ago....it's not a matter of if...it's when...considering the facts and achieved milestones to date,  this future PR in regards to partnership on ANDA(epidiolex), 505b2, or NDA is approaching near term..you have the board president, Mr Strachan on X venting for the FDA to "hurry up".. and when that PR drops jumping into a massive GAP UP isn't ideal.. once trading resumes it could open to anyone's guess....75c...85c...1+$ a share..a new cannabis based drug hitting the U.S market is national news..and I'm betting my bottom dollar it's very soon.   
<< Previous
Bullboard Posts
Next >>